Recombinant human papillomavirus bivalent (type 16/18) vaccine(Pichia pastoris) (Jiankangyuan Biology Medicine)

重组(毕赤酵母)人乳头瘤病毒双价(16/18型)疫苗（健康元生物医药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human papillomavirus bivalent (type 16/18) vaccine(Pichia pastoris) (Jiankangyuan Biology Medicine)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (IND)

Highest Status in ChinaDiscontinued

Originator CompaniesZhuhai Jiankangyuan Biology Medicine Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZhuhai Jiankangyuan Biology Medicine Co Ltd

Active IndicationsN/A

Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A